| Oct 30 |
FTSE 100 Live 30 October: Next forecasts £1bn profit, GSK vaccine sales weakness hits shares
|
| Oct 30 |
GSK sales hampered by slump in demand for key vaccine
|
| Oct 30 |
GSK reports Q3 result, confirms FY guidance
|
| Oct 30 |
GSK to acquire Chimagen’s CMG1A46 for autoimmune disease
|
| Oct 30 |
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q2 2024 Earnings Call Highlights: Revenue ...
|
| Oct 30 |
GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demand
|
| Oct 29 |
GSK to acquire lupus drug candidate CMG1A46 for up to $850M
|
| Oct 29 |
GSK Q3 2024 Earnings Preview
|
| Oct 26 |
GSK Q3 Earnings Preview: Shingrix And Arexvy Make The Stock A 'Strong Buy'
|
| Oct 25 |
GSK stays in red for seven straight sessions
|
